tiprankstipranks
Trending News
More News >
Rapt Therapeutics Inc (RAPT)
NASDAQ:RAPT

Compare RAPT Therapeutics (RAPT) vs. Competitors

Compare
446 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RAPT Therapeutics
$57.68
$1.60B
532.46%
1 Buy
9 Hold
0 Sell
Hold
Neurogene
$17.66
$273.55M
-3.99
13.72%
6 Buy
0 Hold
0 Sell
Strong Buy
DBV Technologies SA - American
$21.61
$906.71M
-4.12
407.28%
5 Buy
0 Hold
0 Sell
Strong Buy
Autolus Therapeutics
$1.37
$364.61M
-1.62
-37.73%
5 Buy
0 Hold
0 Sell
Strong Buy
enGene Holdings
$9.53
$638.36M
-4.15
34.23%
8 Buy
1 Hold
0 Sell
Strong Buy
Lexeo Therapeutics, Inc.
$7.41
$540.84M
-2.74
41.14%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RAPT
RAPT Therapeutics
57.68
48.56
532.46%
NGNE
Neurogene
17.66
0.82
4.87%
DBVT
DBV Technologies SA - American
21.61
17.55
432.27%
AUTL
Autolus Therapeutics
1.37
-0.74
-35.07%
ENGN
enGene Holdings
9.53
2.84
42.45%
LXEO
Lexeo Therapeutics, Inc.
7.41
1.86
33.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts